Propanc Biopharma, Inc.

Biotechnology • Healthcare • Camberwell, VIC, United States • PPCB (NCM)

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. The company was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. Propanc Biopharma, Inc. was incorporated in 2007 and is based in Camberwell, Australia.

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Propanc Biopharma, Inc. had layoffs?

No layoff events have been recorded for Propanc Biopharma, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Propanc Biopharma, Inc. have?

Propanc Biopharma, Inc. has approximately 1 employees.

What industry is Propanc Biopharma, Inc. in?

Propanc Biopharma, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Propanc Biopharma, Inc. a publicly traded company?

Yes, Propanc Biopharma, Inc. is publicly traded under the ticker symbol PPCB on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Propanc Biopharma, Inc. headquartered?

Propanc Biopharma, Inc. is headquartered in Camberwell, VIC, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.